Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EBCC: European Breast Cancer Conference

2.

Aster Whitefield Hospital, with 506 beds, opened.

3.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

4.

Modified personalized cancer vaccine generates powerful immune response

5.

Knowing about and avoiding bladder cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot